Latest filings (excl ownership)
DEF 14A
Definitive proxy
25 Jun 24
PRER14A
Preliminary revised proxy
25 Jun 24
8-K
Entry into a Material Definitive Agreement
17 Jun 24
8-K
Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility
13 Jun 24
PRE 14A
Preliminary proxy
5 Jun 24
8-K
Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit
5 Jun 24
253G3
Offering circular supplement
4 Jun 24
8-K
Entry into a Material Definitive Agreement
4 Jun 24
8-K/A
Entry into a Material Definitive Agreement
3 Jun 24
8-K
Regulation FD Disclosure
31 May 24
QUALIF
Notice of qualification
31 May 24
8-K
Entry into a Material Definitive Agreement
30 May 24
1-A/A
Offering $12.93 mm in Equity
30 May 24
1-A/A
Offering $12.93 mm in Equity
29 May 24
424B3
Prospectus supplement
29 May 24
8-K
Regulation FD Disclosure
28 May 24
8-K
Entry into a Material Definitive Agreement
24 May 24
1-A
Offering $12.93 mm in Equity
21 May 24
10-Q
2024 Q1
Quarterly report
14 May 24
10-K
2023 FY
Annual report
29 Mar 24
8-K
Entry into a Material Definitive Agreement
8 Mar 24
8-K
Regulation FD Disclosure
7 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 Jan 24
8-K
Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems
18 Jan 24
8-K
Changes in Registrant's Certifying Accountant
22 Dec 23
8-K
Departure of Directors or Certain Officers
20 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
DEF 14A
Definitive proxy
7 Nov 23
PRE 14A
Preliminary proxy
27 Oct 23
EFFECT
Notice of effectiveness
27 Oct 23
CORRESP
Correspondence with SEC
24 Oct 23
UPLOAD
Letter from SEC
24 Oct 23
S-1
IPO registration
16 Oct 23
8-K
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
3 Oct 23
424B5
Prospectus supplement for primary offering
29 Sep 23
8-K
Regulation FD Disclosure
28 Sep 23
8-K
Signed term sheet providing for up to $75 Million in debt financing to be used for the acquisition
26 Sep 23
EFFECT
Notice of effectiveness
6 Sep 23
CORRESP
Correspondence with SEC
31 Aug 23
S-3/A
Shelf registration (amended)
29 Aug 23
Latest ownership filings
4
Timothy James Ruemler
30 Apr 24
4
Soren Bo Christiansen
30 Apr 24
4
Jason L. Monroe
30 Apr 24
4
Robert Michael Hayes
30 Apr 24
4
PAUL K DANNER
30 Apr 24
4
Brenda Baird Simpson
30 Apr 24
4
Andrew R. Crescenzo
30 Apr 24
4
Robert Michael Hayes
21 Feb 24
SC 13G
Walleye Capital LLC
14 Feb 24
4
Robert Michael Hayes
7 Feb 24
4
Robert Michael Hayes
5 Feb 24
SC 13G
Empery Asset Management, LP
9 Jan 24
4
Timothy James Ruemler
4 Jan 24
4
Andrew R. Crescenzo
29 Dec 23
4
Timothy James Ruemler
22 Dec 23
4
Timothy James Ruemler
27 Nov 23
4
Timothy James Ruemler
24 Nov 23
4
Timothy James Ruemler
21 Nov 23
4
Timothy James Ruemler
17 Nov 23
4
Robert Michael Hayes
18 Apr 23
4
Robert Michael Hayes
15 Mar 23
4
Robert Michael Hayes
22 Feb 23
4
Brenda Baird Simpson
27 Jan 23
4
Timothy James Ruemler
27 Jan 23
4
Jason L. Monroe
27 Jan 23
4
Robert Michael Hayes
27 Jan 23
4
PAUL K DANNER
27 Jan 23
4
Andrew R. Crescenzo
27 Jan 23
4
Soren Bo Christiansen
27 Jan 23
4
Alan R. Blackman
27 Jan 23
4
Robert Michael Hayes
7 Sep 22
4
Robert Michael Hayes
1 Sep 22
4
Robert Michael Hayes
30 Aug 22
4
Robert Michael Hayes
24 Aug 22
4
Robert Michael Hayes
8 Aug 22
4
Robert Michael Hayes
2 Aug 22
4
Robert Michael Hayes
18 Jul 22
4
Robert Michael Hayes
23 May 22
4
Timothy James Ruemler
11 May 22
4
Andrew R. Crescenzo
9 May 22